362 related articles for article (PubMed ID: 11828341)
41. Novel alpha-galactosidase A mutation in a female with recurrent strokes.
Tuttolomondo A; Duro G; Miceli S; Di Raimondo D; Pecoraro R; Serio A; Albeggiani G; Nuzzo D; Iemolo F; Pizzo F; Sciarrino S; Licata G; Pinto A
Clin Biochem; 2012 Nov; 45(16-17):1525-30. PubMed ID: 22820434
[TBL] [Abstract][Full Text] [Related]
42. The entire genomic sequence and cDNA expression of mouse alpha-galactosidase A.
Gotlib RW; Bishop DF; Wang AM; Zeidner KM; Ioannou YA; Adler DA; Disteche CM; Desnick RJ
Biochem Mol Med; 1996 Apr; 57(2):139-48. PubMed ID: 8733892
[TBL] [Abstract][Full Text] [Related]
43. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
[TBL] [Abstract][Full Text] [Related]
44. Naked plasmid DNA-based alpha-galactosidase A gene transfer partially reduces systemic accumulation of globotriaosylceramide in Fabry mice.
Nakamura G; Maruyama H; Ishii S; Shimotori M; Kameda S; Kono T; Miyazaki J; Kulkarni AB; Gejyo F
Mol Biotechnol; 2008 Feb; 38(2):109-19. PubMed ID: 18219591
[TBL] [Abstract][Full Text] [Related]
45. Alpha-galactosidase gene mutations in Fabry disease: heterogeneous expressions of mutant enzyme proteins.
Okumiya T; Ishii S; Kase R; Kamei S; Sakuraba H; Suzuki Y
Hum Genet; 1995 May; 95(5):557-61. PubMed ID: 7759078
[TBL] [Abstract][Full Text] [Related]
46. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A).
Hwu WL; Chien YH; Lee NC; Chiang SC; Dobrovolny R; Huang AC; Yeh HY; Chao MC; Lin SJ; Kitagawa T; Desnick RJ; Hsu LW
Hum Mutat; 2009 Oct; 30(10):1397-405. PubMed ID: 19621417
[TBL] [Abstract][Full Text] [Related]
47. [alpha-Galactosidase gene mutation and its expression product in Fabry disease (alpha-galactosidase deficiency)].
Okumiya T; Takata T; Sasaki M; Sakuraba H
Rinsho Byori; 1997 Feb; 45(2):127-35. PubMed ID: 9120996
[TBL] [Abstract][Full Text] [Related]
48. [Molecular genetics of inherited metabolic diseases--its application to the investigation of pathogenesis and the diagnosis of Fabry disease].
Sakuraba H
Rinsho Byori; 1994 Jun; 42(6):628-35. PubMed ID: 7914243
[TBL] [Abstract][Full Text] [Related]
49. Identification of a novel loss-of-function mutation of the GLA gene in a Chinese Han family with Fabry disease.
Zhou C; Huang J; Cui G; Zeng H; Wang DW; Zhou Q
BMC Med Genet; 2018 Dec; 19(1):219. PubMed ID: 30587147
[TBL] [Abstract][Full Text] [Related]
50. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
Hovhannisyan RH; Carstens RP
Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
[TBL] [Abstract][Full Text] [Related]
51. Abnormal Pre-mRNA Splicing in Exonic Fabry Disease-Causing GLA Mutations.
Alfen F; Putscher E; Hecker M; Zettl UK; Hermann A; Lukas J
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499585
[TBL] [Abstract][Full Text] [Related]
52. Recombinant enzyme therapy for Fabry disease: absence of editing of human alpha-galactosidase A mRNA.
Blom D; Speijer D; Linthorst GE; Donker-Koopman WG; Strijland A; Aerts JM
Am J Hum Genet; 2003 Jan; 72(1):23-31. PubMed ID: 12471562
[TBL] [Abstract][Full Text] [Related]
53. A novel 6 bp insertion in exon 7 associated with an unusual phenotype in a family with Fabry disease.
Kroepfl T; Paul K; Kotanko P; Plecko B; Paschke E
J Inherit Metab Dis; 2002 Dec; 25(8):695-6. PubMed ID: 12705499
[TBL] [Abstract][Full Text] [Related]
54. A novel mutation (c.951C>T) in an exonic splicing enhancer results in exon 10 skipping in the human mitochondrial acetoacetyl-CoA thiolase gene.
Fukao T; Horikawa R; Naiki Y; Tanaka T; Takayanagi M; Yamaguchi S; Kondo N
Mol Genet Metab; 2010 Aug; 100(4):339-44. PubMed ID: 20488739
[TBL] [Abstract][Full Text] [Related]
55. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Davis RL; Homer VM; George PM; Brennan SO
Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
[TBL] [Abstract][Full Text] [Related]
56. Fabry disease: twenty novel alpha-galactosidase A mutations and genotype-phenotype correlations in classical and variant phenotypes.
Germain DP; Shabbeer J; Cotigny S; Desnick RJ
Mol Med; 2002 Jun; 8(6):306-12. PubMed ID: 12428061
[TBL] [Abstract][Full Text] [Related]
57. Two novel mutations in the alpha-galactosidase gene in Japanese classical hemizygotes with Fabry disease.
Okumiya T; Takenaka T; Ishii S; Kase R; Kamei S; Sakuraba H
Jpn J Hum Genet; 1996 Sep; 41(3):313-21. PubMed ID: 8996967
[TBL] [Abstract][Full Text] [Related]
58. Identification of an alternative splicing isoform of chicken Lmbr1.
Huang Y; Chen W; Li N; Deng X; Kang X; Liu X
Mol Biol Rep; 2011 Oct; 38(7):4397-403. PubMed ID: 21161408
[TBL] [Abstract][Full Text] [Related]
59. Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts.
Bishop DF; Schneider-Yin X; Clavero S; Yoo HW; Minder EI; Desnick RJ
Blood; 2010 Feb; 115(5):1062-9. PubMed ID: 19965637
[TBL] [Abstract][Full Text] [Related]
60. Oligosymptomatic cornea verticillata in a heterozygote for Fabry disease: a novel mutation in the alpha-galactosidase gene.
Kono JO; Podskarbi T; Shin Y; Lanzl I
Cornea; 2003 Mar; 22(2):175-7. PubMed ID: 12605057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
